UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
Why solar flares are way hotter than researchers thought
The hottest parts of the sun are its solar flares, and a new study suggests these flares could be more than six times hotter than scientists used to believe.
Ivey, Ledbetter go to court to try and allow voucher students to participate in athletics
Gov. Kay Ivey and House Speaker Nathaniel Ledbetter filed the complaint in Montgomery Circuit Court against the Alabama High School Athletic Association. They are asking a judge to block the association's ruling on eligibility and pave the way for the students to participate in athletics this year.
The world’s oldest and largest iceberg will soon be no more
The iceberg, known as A23a, has been on a journey following the current into warmer waters for months. Now, it has begun the predicted and natural process of breaking apart, and eventually melting.
Etsy sellers are being hit hard by tariffs and the end of the de minimis rule
For years, the U.S. was essentially "an extension of our domestic market," says an Etsy seller in Canada. But now the rules and costs are far more imposing.
What ICE agents can and cannot legally do during arrests
Tactics by immigration agents attempting to arrest undocumented immigrants have shocked the public and led to protests. But what is, and isn't, allowed by law when it comes to ICE arrests?
Trump’s D.C. takeover has led to more arrests. NPR looks at cases of those swept up
NPR combed through court records and other data related to Trump's takeover of D.C. police to get a better understanding of who has been swept up in the federal surge and what charges they are facing.
